Snapdragon Chemistry is proud to announce that Matthew Bio, Ph.D., will join as its Chief Scientific Officer. Dr. Bio brings a wealth of leadership and expertise in cutting-edge chemical synthesis development to Snapdragon Chemistry during an exciting point in Snapdragon Chemistry's growth; he shares Snapdragon's passion for helping companies harness continuous flow synthesis to drive unparalleled value in their operations.
Dr. Bio comes to Snapdragon Chemistry from Amgen Inc., where he most recently served as Director of Process Development and Head of the Synthetic and Hybrid Technologies group. At Amgen, he was responsible for setting the scientific direction of process development for synthetic drug candidates and for leading development of the first continuous process at Amgen.
Aaron Beeler, our co-founder, acting CSO, and Assistant Professor of Chemistry at Boston University, will continue to remain actively engaged as the company’s Synthetic Technologies Advisor.